Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
18.16 HKD | -1.30% | +0.44% | -23.06% |
Apr. 22 | Cansino Bio Gets Nod for China Clinical Trials of Haemophilus Influenzae Vaccine | MT |
Apr. 22 | Cansino Biologics Pneumococcal Vaccine's Phase I Trial Offers Positive Results | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.06% | 1.08B | |
-2.86% | 87.37B | |
+4.08% | 41.01B | |
-25.35% | 28.08B | |
+54.31% | 24.72B | |
-4.52% | 17.47B | |
-42.09% | 11.69B | |
-17.77% | 11.6B | |
-12.10% | 11.56B | |
+0.75% | 8.44B |
- Stock Market
- Equities
- 6185 Stock
- News CanSino Biologics Inc.
- UBS Adjusts CanSino Biologics’ Price Target to HK$200 From HK$202, Keeps at Buy